Articles & insights
Compliance Programmes, Audits & Training
Designing, auditing and embedding healthcare compliance programmes, policies and training.
Pharma Compliance Across the Product Lifecycle
How pharma and biotech companies can connect risk-based compliance across clinical development, pre-launch, launch and commercialisation.
Read the article 2026-09-30The ABPI Signatory: Certification Requirements, Role and Training
What the 2024 ABPI Code requires of signatories: who can certify, what must be certified, notifying the MHRA and PMCPA, recertification and records.
Read the article 2026-07-30How Small and Mid-Sized Pharma Companies Can Build an Effective Compliance Risk Assessment Framework
How small and mid-sized pharma can build a compliance risk assessment framework: focus on high-risk activities and make assessment continuous.
Read the article 2026-06-02Right-Sized Compliance Support: Meeting the Needs of Both Emerging Biotech and Global Pharma
Right-sized compliance: foundational controls for emerging biotech, integrated governance for global pharma, and how to build compliance that scales.
Read the article 2026-04-01Scalable Compliance Models for Growing Pharma in the Age of AI
Scalable compliance models for growing pharma and biotech in the AI era: a four-tier approach of advisory, outsourcing, shared services and centralisation.
Read the article 2026-03-30Entering Phase III? Compliance Expectations Already Have
Why Phase III is when compliance becomes essential for biotech: EFPIA and transparency expectations, early commercial activity and scalable controls.
Read the article 2026-02-27Compliance Gap Analysis: Reducing Risk Without Slowing Growth
How a compliance gap analysis shows where policies no longer match how the business operates, so pharma teams reduce risk without adding controls.
Read the article 2025-12-24Beyond the Checklist: How Gap Analysis Strengthens Healthcare Compliance Internal Audits
Why checklist-driven internal audits give false comfort, and how gap analysis makes healthcare compliance audits risk-focused for small and mid-sized pharma.
Read the article 2025-10-24Staying Ahead of the Curve: Audit-Readiness Best Practices Across European Life Sciences Markets
Prepare pharma teams for compliance audits with harmonised SOPs, monitoring, a consistent FMV framework, training and clear evidence records.
Read the article 2025-10-03Top 10 Healthcare Compliance Challenges in Pharma Industry and How to Solve Them
The top 10 compliance challenges in pharma, from material review and HCP fair market value to third parties, ABAC and cross-border rules, with solutions.
Read the article 2025-10-03What Makes Healthcare Compliance Training Effective?
What makes compliance training effective: learning styles, Bloom's taxonomy, and why clear, bite-sized, tailored and practical training works.
Read the article 2025-09-16How to Avoid Common Healthcare Compliance Mistakes in Pharmaceuticals
Six common pharma compliance mistakes, from unbalanced materials and unjustified hospitality to weak third-party oversight, and how to prevent them.
Read the article 2025-08-26Compliance Training: Beyond the Code
Why compliance training fails as a checkbox. Lessons from a PMCPA case on role clarity and escalation, and how scenario-based training builds ownership.
Read the article 2025-08-11A Definitive Guide to Crafting a high-quality Policy for a Pharmaceutical Company
How to write a pharma compliance policy that works in practice: as-is and gap analysis, workflow mapping, Six Sigma structure and the sections to include.
Read the article 2025-06-05Risk Assessment in Healthcare and its Importance
What risk assessment in healthcare involves, why it matters for patient safety, data privacy and compliance, and how to build a risk framework.
Read the article 2025-03-19Importance of Bespoke Healthcare Compliance Training for Pharmaceutical Industry
Why pharma compliance training should be bespoke: turning complex EFPIA, IFPMA, ABPI and FSA requirements into practical training for each audience.
Read the article 2025-03-07Managing compliance Risks: Best Practices & Strategies
Managing compliance risk in pharma: off-label promotion, bribery, conflicts of interest and data privacy, the consequences, and how to manage them.
Read the articleQuestions, answered
Compliance Programmes, Audits & Training: common questions
What does a pharmaceutical compliance programme include?
Governance and roles, practical policies and SOPs, approval and monitoring processes, evidence requirements and role-based training, aligned to the obligations that apply to your activities and markets.
What is audit readiness?
A continuous state in which documentation, controls, evidence and governance are built into routine operations, rather than assembled immediately before an audit.